Company intelligence / Profile preview

New River Quality Consulting

Ownership: Private
Development stage: Commercial

Overview

New River Quality Consulting, LLC is led by Mary Becker-Pashanamaei, who also serves as the lead Quality Assurance consultant at Incyte Corporation. The firm appears to provide quality assurance consulting services within the pharmaceutical or biotech sector but does not develop its own clinical programs[3].

Industry: Consulting

Drug pipeline

1 asset

ruxolitinib

Commercial

Indications: Myelofibrosis, Polycythemia vera, Graft-versus-host disease

Beyond the preview

Go deeper on New River Quality Consulting.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on New River Quality Consulting.

Explore the full profile